LATEST EDUCATION
HEMATOLOGY
Advances in the Therapeutic Management of PNH (Paroxysmal Nocturnal Hemoglobinuria)
- Explain how impairment in the complement pathway contributes to the pathophysiologic issues in PNH
- Identify how current and emerging therapies target the complement pathway in patients with PNH
- Outline safety and efficacy of new and emerging therapies for PNH Associate potential clinical impact of emerging therapies in addressing limitations of current treatments in patients with PNH
Addressing the Unmet Needs in Myelofibrosis Management
- Explain the pathophysiologic mechanisms involved in the development of MF and progression of the disease
- Describe the burden of disease and impact on QoL for patients with MF and as a consequence of current treatments
- Identify current and future goals for managing MF based on therapeutic targets for improved overall survival
- Compare and contrast clinical data on new and emerging agents for myelofibrosis with a focus on improving QOL
- Identify strategies to prevent, monitor, and manage treatment related adverse effects
- Recognize approaches to ensure shared decision-making and equitable care with patients
NEUROLOGY
ONCOLOGY
PSYCHIATRY
PULMONARY
0
Providers Educated
0
Accredited Activities
0
Hours of Instruction
0
Founded
HAPPY CLIENTS
What actually we do
